Most cited article(s)
- Recent trials of antioxidant therapy: What should we be telling our patients?
Evidence does not support the indiscriminate use of vitamins A, C, or E or beta carotene to prevent or reduce cardiovascular disease.
- Systemic diseases associated with intermediate uveitis
Multiple sclerosis, inflammatory bowel disease, thyroid abnormalities, and possible Epstein-Barr virus infection were among the findings in 26 of 83 intermediate uveitis patients.
- Recognizing and treating diabetic autonomic neuropathy
Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.
- Preventing and treating orthostatic hypotension: As easy as A, B, C
Easy-to-remember management recommendations, using a combination of effective drug and nondrug treatments.
- Should anticoagulation be resumed after intracerebral hemorrhage?
In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.
Acute and critical limb ischemia: When time is limbJust as in acute myocardial infarction, where “time is muscle,” in many cases of vascular disease in the leg, “time is limb.”
- Diffuse alveolar hemorrhage: Diagnosing it and finding the cause
Diffuse alveolar hemorrhage can complicate a large number of clinical conditions. It may present in different ways and may be life-threatening, and it poses an important challenge for the clinician.
- How to prevent, recognize, and treat drug-induced nephrotoxicity
How drugs injure the kidney, who is at risk, and how to prevent renal injury.